Brief Summary
The primary purpose of this study is to evaluate the anti-tumor activity of TLN-254 monotherapy in participants with relapsed or refractory T-cell lymphoma.
Protocol Interventions
Drug: TLN-254
- Make an AppointmentAppointments
Make an Appointment
Let Siteman's care coordinators guide you through your next best step. Their oncology expertise means you are in good hands.Start with Siteman
Talk With Us
Currently in Treatment at Siteman